They are not drugs, foods, supplements, or cosmetics, are not approved by the FDA, and are not intended to diagnose, treat, cure, or prevent any disease, or for human or veterinary consumption
The semaglutide timeline article and week-by-week results guide provide detailed progression information
As research grows, thoughtful design and personalized treatment plans may be key to unlocking their full potential.
Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits
This compares to approximately 23% weight loss with diet and exercise alone
Paolella, L